HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of WY 47987 (atrial natriuretic factor 102-126) in patients with renal insufficiency: a placebo-controlled, randomised study.

Abstract
We studied renal, hormonal and cardiovascular effects of ANF 102-126 (WY 47987) in seven patients with chronic renal failure (serum creatinine 25-68 mg/l) and in four normal volunteers. ANF or placebo bolus injections were given at 1, 2, and 3 micrograms/kg i.v. (each dose on separate days). As compared to placebo, ANF did not induce changes of renal excretory parameters, of plasma renin and aldosterone or of blood pressure and heart rate in patients. In healthy volunteers, however, the same dose of ANF increased urinary excretion of sodium, potassium, calcium, chloride and phosphorus as well as water, and creatinine clearances, and decreased plasma aldosterone. The data suggest blunted effectiveness of ANF bolus injections in patients with renal insufficiency.
AuthorsJ F Mann, C Reisch, R Bergbreiter, D Karcher, E Hackenthal, P Vecsei, J Nussberger, E Ritz
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 4 Issue 9 Pg. 776-81 ( 1989) ISSN: 0931-0509 [Print] England
PMID2533973 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptide Fragments
  • anaritide
  • Phosphorus
  • Aldosterone
  • Atrial Natriuretic Factor
  • Renin
  • Potassium
Topics
  • Aldosterone (blood)
  • Atrial Natriuretic Factor (adverse effects, therapeutic use)
  • Hemodynamics (drug effects)
  • Humans
  • Kidney Failure, Chronic (drug therapy)
  • Male
  • Middle Aged
  • Natriuresis (drug effects)
  • Peptide Fragments (adverse effects, therapeutic use)
  • Phosphorus (urine)
  • Potassium (urine)
  • Randomized Controlled Trials as Topic
  • Renin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: